Epidemiology of Gestational Trophoblastic Diseases

  • Jonathan Buckley
Part of the Clinical Perspectives in Obstetrics and Gynecology book series (CPOG)

Abstract

The gestational trophoblastic diseases have, until recently, attracted relatively little attention from epidemiologists. The many descriptive studies that have been conducted over the last four decades have helped to define the geographic distribution of these diseases and have provided evidence for a large number of potential risk factors. In general these studies, while serving to generate new and interesting hypotheses, have not been designed to adequately evaluate the significance of these disease associations, or to consider the question of interrelationships between the various factors. The testing of hypotheses requires a different approach, such as the traditional casecontrol design, which compares the data obtained from women included in a case series to those obtained from a carefully selected control group, and it is only in the last few years that full-scale case-control studies on the trophoblastic diseases have been undertaken. A major stimulus to renewed activity has come from recent insights into the biology and genetics of hydatidiform moles, which have served to better define the pathological entities of complete and partial moles. Knowledge of the cellular mechanisms involved has naturally led to questions concerning possible environmental or familial (genetic) factors that may be associated with, or predispose to, the observed events.

Keywords

Estrogen Income Tuberculosis Oncol Smoke 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hertig AT, Edmonds HW. Genesis of hydatidiform mole. Arch Pathol. 1940; 30:260–291.Google Scholar
  2. 2.
    Morrow CP, Kletzky OA, Disaia PJ, et al. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynec. 1977; 128:424–429.PubMedGoogle Scholar
  3. 3.
    Hilgers RD, LewisJL. Gestationaltrophoblastic neoplasms. Gynec Oncol. 1974; 2:460–475.CrossRefGoogle Scholar
  4. 4.
    Grimes DA. Epidemiology of gestational trophoblastic disease. Am J Obstet Gynecol. 1984; 150:309–318.PubMedGoogle Scholar
  5. 5.
    Bracken MB, Brinton LA, Hayashi K. Epidemiology of hydatidiform mole and choriocarcinoma. Epidem Rev. 1984; 6:52–75.Google Scholar
  6. 6.
    Buckley JD. The epidemiology of molar pregnancy and choriocarcinoma. Clin Obstet Gynec. 1984; 27: 153–159.PubMedCrossRefGoogle Scholar
  7. 7.
    Szulman AE, Philippe E, Boue JG, et al. Human triploidy: association with partial hydatidiform moles and nonmolar conceptuses. Hum Pathol. 1981; 12: 1016–1021.PubMedCrossRefGoogle Scholar
  8. 8.
    Matsuura J, Chiu D, Jacobs PA, et al. Complete hydatidiform mole in Hawaii: an epidemiological study. Genet Epidemiol. 1984; 1:271–284.PubMedCrossRefGoogle Scholar
  9. 9.
    Jacobs PA, Hunt PA, MatsuuraJS, et al. Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynec. 1982; 89:258–266.CrossRefGoogle Scholar
  10. 10.
    Lawler SD. Genetic studies on hydatidiform moles. Adv Exp Med Biol. 1984; 176: 147–161.PubMedGoogle Scholar
  11. 11.
    La Vecchia C, Francheschi S, Fasoli M, et al. Gestational trophoblastic neoplasms in homozygous twins. Obstet Gynecol 1982; 60:250–252.PubMedGoogle Scholar
  12. 12.
    Messerli ML, Lilienfeld AM, Parmley T, et al. Risk factors for gestational trophoblastic neoplasia. Am J Obstet Gynecol. 1985; 153:294–300.PubMedGoogle Scholar
  13. 13.
    Szulman AE, Surti V. The syndromes of hydatidiform mole. 1. Cytogenetic and morphologic correlations. Am J Obstet Gynecol. 1978; 131:665–671.PubMedGoogle Scholar
  14. 14.
    DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology. CV Mosby Co, St Louis. 1984.Google Scholar
  15. 15.
    Nielsen NH, Hansen JPH. Trophoblastic tumors in Greenland. J Cancer Res Clin Oncol. 1979; 95:177–86.PubMedCrossRefGoogle Scholar
  16. 16.
    Matalon M, Modan B. Epidemiological aspects of hydatidiform mole in Israel. Am J Obstet Gynecol. 1972; 112: 107–111.PubMedGoogle Scholar
  17. 17.
    Teoh ES, Dawood MY, Ratnam SS. Epidemiology of hydatidiform mole in Singapore. Am J Obstet Gynecol. 1971; 110:415–420.PubMedGoogle Scholar
  18. 18.
    Yen S, MacMahon B. Epidemiologic features of trophoblastic disease. Am J Obstet Gynecol.1968; 101: 126–132.PubMedGoogle Scholar
  19. 19.
    Wei PY, Ouyang PC. Trophoblastic diseases in. Taiwan. Am J Obstet Gynecol. 1963; 85:258–266.Google Scholar
  20. 20.
    Report of a WHO scientific group. Gestational trophoblastic diseases. Geneva, WHO, 1983 (Technical Report Series 692).Google Scholar
  21. 21.
    Poen HT, Djojoprantoto M. The possible etiologic factors of hydatidiform mole and choriocarcinoma. Am J Obstet Gynecol. 1965; 92:510–513.PubMedGoogle Scholar
  22. 22.
    Marquez-Monter H, de la Vega GA, Ridaura C, et al. Gestational choriocarcinoma in the general hospital of Mexico. Cancer 1968; 22:91–98.PubMedCrossRefGoogle Scholar
  23. 23.
    Saleh JS, Pourmand K, Mojaradi N. A study of the trophoblastic disease among the Iranian population. Br J Clin Pract. 1966; 20: 119–127.PubMedGoogle Scholar
  24. 24.
    Song H, Wu B, Tang M, et al. Trophoblastic tumors: diagnosis and treatment. Capital Hospital, Beijing, China, 1981.Google Scholar
  25. 25.
    National Coordination Research Group of Choriocarcinoma. Incidence of hydatidiform mole (a retrograde study of 2,023,621 women in 23 provinces). Zhonghua Yixue Zazhi. 1980; 60:641–644.Google Scholar
  26. 26.
    Martin PM. High frequency of hydatidiform mole in native Alaskans. Int J Gynaecol Obstet. 1978; 15:395–396.PubMedGoogle Scholar
  27. 27.
    Miller FL, Barnhardt RJ. Mixed marriage may offer Asian women protection against hydatidiform mole. Ob Gyn News. 1975; 10:16.Google Scholar
  28. 28.
    Iliya FA, Williamson S, Azar HA. Choriocarcinoma in the Near East: consanguinity as a possible etiological factor. Cancer 1967; 20: 144–149.PubMedCrossRefGoogle Scholar
  29. 29.
    McCorriston CC. Racial incidence of hydatidiform mole. Am J Obstet Gynecol. 1968; 101:377–382.PubMedGoogle Scholar
  30. 30.
    Nakano R, Sasaki K, Yamoto M, Hata H. Trophoblastic disease: Analysis of 342 patients. Gynecol Obstet Invest 1980; 11:237–242.PubMedCrossRefGoogle Scholar
  31. 30a.
    Hayashi K, Bracken MB, Freeman DH, et al. Hydatidiform mole in the United States (10701977): A statistical and theoretical analysis. Am J Epidem. 1982; 115:67–77.Google Scholar
  32. 31.
    Rolon PA, de Lopez BH. Epidemiological aspects of hydatidiform mole in the Republic of Paraguay (South America). Br J Obstet Gynecol.1977; 84:862–864.CrossRefGoogle Scholar
  33. 32.
    Likeman RK. Choriocarcinoma in Auckland: A retrospective study of 27 cases. NZ Med J.1981; 93:426–429.Google Scholar
  34. 33.
    Llewellyn-Jones D. Trophoblastic tumours. Geographic variations in incidence and possible aetiological factors. J Obstet Gynecol 242–248.Google Scholar
  35. 34.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI. 1959; 22:719–748.PubMedGoogle Scholar
  36. 35.
    La Vecchia C, Parazzini F, Decarli A, et al. Age of parents and risk of gestational trophoblastic disease. JNCI. 1984; 73:639–642.PubMedGoogle Scholar
  37. 36.
    Shang E, Xu L, Wei M. A retrospective study on incidence of hydatidiform mole in 20,548 fertile women. Zhonghua Yixue Zazhi, 1982; 62:282–285.PubMedGoogle Scholar
  38. 37.
    Matalon M, Paz B, Modan M, et al. Malignant trophoblastic disorders. Epidemiological aspects and relationship to hydatidiform mole. AmJ Obstet Gynecol. 1982; 112:101–105.Google Scholar
  39. 38.
    Slocomb JC, Lund CJ. Incidence of trophoblastic disease: increased rate in youngest age group. Am J Obstet Gynecol. 1969; 104:421–423.Google Scholar
  40. 39.
    Baltazar JC. Epidemiological features of choriocarcinoma. Bull WHO. 1976; 54:523–532.PubMedGoogle Scholar
  41. 40.
    Berkowitz RS, Cramer DW, Bernstein MR, et al. Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol. 1985; 152: 1016–1020.PubMedGoogle Scholar
  42. 41.
    Vitamin A deficiency and xerophthalmia. WHO Tech Rep. 1976; 590.Google Scholar
  43. 42.
    Thompson JN, Howell JM, Pitt GAJ. Vitamin A and reproduction in rats. Proc Roy Soc Biol.1964; 159:510–536.PubMedCrossRefGoogle Scholar
  44. 42a.
    La Vecchia C, Franceschi S, Parazzini F, et al. Risk factors for gestational trophoblastic disease in Italy. Am J Epidemiol. 1985; 121:457–464.PubMedGoogle Scholar
  45. 43.
    Park WW, Lees JC. Choriocarcinoma: a general review, with analysis of 516 cases. Arch Pathol. 1950; 49:73–104.Google Scholar
  46. 43a.
    Fisher RA, Lawler SD. Heterozygous complete hydatidiform moles: Do they have a worse prognosis than homozygous complete moles? Lancet. 1984; 2:51.PubMedCrossRefGoogle Scholar
  47. 44.
    Kajii T, Kurashige H, Ohama K, et al. XY and XX complete moles: Clinical and morphological correlations. Am J Obstet Gynecol. 1984; 150:57–74.PubMedGoogle Scholar
  48. 44a.
    Wake N, Seki T, Fujita H, et al. Malignant potential of homozygous and heterozygous complete moles. Cancer Res. 1984; 44:1226–1230.PubMedGoogle Scholar
  49. 45.
    Sheppard DM, Fisher RA, Lawler SD. Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet. 1985; 16:251–251.PubMedCrossRefGoogle Scholar
  50. 46.
    Stone M, Dent J, Kardana A, et al. Relationship of oral contraception to development of trophoblastic tumours after evacuation of a hydatidiform mole. Br J Obstet Gynaecol. 1979; 83:913–916.Google Scholar
  51. 47.
    Yuen BH, Burch P. Relationship of oral contraceptive devices to the regression of concentrations of human chorionic gonadotrophin and invasive complications after molar pregnancy. Am J Obstet Gynecol. 1983; 145:214–217.Google Scholar
  52. 48.
    Berkowitz RS, Mareen AR, Goldstein DP. Oral contraceptives and post-molar trophoblastic tumours. Lancet, 1980; 2:752.PubMedCrossRefGoogle Scholar
  53. 49.
    Schmidt G, Fowler WC, Talbert LM et al. Reproductive history of women exposed to diethylstilbestrol in utero. Fertil Steril. 1980;33:21–24.PubMedGoogle Scholar
  54. 50.
    Ogborn ADR. Hydatidiform mole arising twice during bromocriptine therapy. Br J Obstet Gynaecol. 1977; 84:717–718.PubMedGoogle Scholar
  55. 51.
    Acosta-Sison H. Observations which may indicate the etiology of hydatidiform mole and explain its high incidence in the Philippines and Asiatic countries. Philipp J Surg. 1959; 14:209–297.Google Scholar
  56. 52.
    Hsu CT, Chen TY, Chiu WH, et al. Some aspects of trophoblastic disease peculiar to Taiwan. Am J Obstet Gynecol. 1964; 90:308–316.PubMedGoogle Scholar
  57. 53.
    McGregor C, Ontiveros EC, Vargas EL, et al. Hydatidiform mole: analysis of 145 patients. Obstet Gynecol. 1969; 33:343–351.Google Scholar
  58. 54.
    Teoh ES, Dawood MY, Ratnam SS. Observations on choriocarcinoma in Singapore. Obstet Gynecol. 1972; 40:519–523.PubMedGoogle Scholar
  59. 55.
    LueckJ, Brewer JI, Aladjem S, et al. Observation of an organism found in patients with gestational trophoblastic disease and in patients with toxemia of pregnancy. Am J Obstet Gynecol. 1983; 145:15–26.PubMedGoogle Scholar
  60. 56.
    Lawler SD, Klouda PT, Bagshawe KD. Immunogenicity of molar pregnancies in the HLA system. Am J Obstet Gynecol. 1974; 120:857861.Google Scholar
  61. 57.
    Loke YW, Joysey VC, Borland R. HLA antigens on human trophoblast cells. Nature. 1971; 232:403–405.PubMedCrossRefGoogle Scholar
  62. 58.
    Jones EA, Bodmer WF. Lack of expression of HLA antigens on choriocarcinoma cell lines. Tissue Antigens. 1980; 16: 195–202.PubMedCrossRefGoogle Scholar
  63. 59.
    Bagshawe KD, Lawler SD. Choriocarcinoma, in: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. Philadelphia, WB Saunders, 1982, pp 909–924.Google Scholar
  64. 60.
    Dawood MY, Teoh ES, Ratnam SS. ABO blood group in trophoblastic disease. J Obstet Gynaecol Br Commonw. 1971; 78:918–923.PubMedCrossRefGoogle Scholar
  65. 61.
    Bagshawe KD, Rawlings G, Pike MC, et al. The ABO groups in trophoblastic neoplasia. Lancet. 1971; 1:553–557.PubMedCrossRefGoogle Scholar
  66. 62.
    Yamashita K, Ishikawa M, Shimizu T, et al. HLA antigens in husband-wife pairs with trophoblastic tumor. Gynecol Oncol. 1981; 12:68–74.PubMedCrossRefGoogle Scholar
  67. 63.
    Lawler SD. HLA and trophoblastic tumors. Br Med Bull. 1978; 34:305–308.PubMedGoogle Scholar
  68. 64.
    Lawler SD, Klouda PT, Bagshawe KD. The HLA system in prophoblastic neoplasia. Lancet. 1971; 2:834–837.PubMedCrossRefGoogle Scholar
  69. 65.
    Federscheinder FM, Goldstein DP, Berkowitz RS, et al. Natural history of recurrent molar pregnancy. Obstet Gynecol. 1980; 55:457–459.Google Scholar
  70. 66.
    Mack HC, Catherwood AE. The Ascheim-Zondek reaction in hydatidiform mole and malignant chorioepithelioma. Am J Obstet Gynecol. 1930; 20:670–678.Google Scholar
  71. 67.
    Goldstein DP, Berkowitz RS, Bernstein MR. Reproductive performance after molar pregnancy and gestational trophoblastic tumors. Clin Obstet Gynecol. 1984; 27:221–227.PubMedCrossRefGoogle Scholar
  72. 68.
    De George FV. Hydatidiform moles in other pregnancies of mothers of twins. Am J Obstet Gynecol. 1970; 108:369–371.PubMedGoogle Scholar
  73. 69.
    Ambani LM, Vaidya RA, Rao CS, et al. Familial occurrence of trophoblastic disease: report of recurrent molar pregnancies in sisters in three families. Clin Genet. 1980; 18:27–29.PubMedCrossRefGoogle Scholar
  74. 70.
    Kolstad P, Hognestad J. Trophoblastic tumours in Norway. Acta Obstet Gynec Scand.1965; 44:80–88.PubMedCrossRefGoogle Scholar
  75. 71.
    Ringertz N. Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958–1965. Acta Obstet Gynec Scand. 1970; 49: 195–203.PubMedCrossRefGoogle Scholar
  76. 72.
    Shanmugaratnam K, Mui CS, Tow SH, et al. Rates per 100,000 births and incidence of choriocarcinoma and malignant mole in Singapore Chinese and Malays. Comparison with Connecticut, Norway and Sweden. Int J Cancer.1971; 8: 165–175.PubMedCrossRefGoogle Scholar
  77. 73.
    Rolon PA, de Lopez BH. Malignant trophoblastic disease in Paraguay. 1979; 23:94–96.Google Scholar
  78. 74.
    Sengupta BS, Persaud V, Wynter HH. Choriocarcinoma in Jamaica. Int Surg. 1977; 62:84–87.PubMedGoogle Scholar
  79. 75.
    Leighton PC. Trophoblastic disease in Uganda. Am J Obstet Gynecol. 1973; 117:341–344PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1987

Authors and Affiliations

  • Jonathan Buckley

There are no affiliations available

Personalised recommendations